BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 25853296)

  • 1. PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein.
    Ciron C; Zheng L; Bobela W; Knott GW; Leone TC; Kelly DP; Schneider BL
    Acta Neuropathol Commun; 2015 Apr; 3():16. PubMed ID: 25853296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function.
    Ciron C; Lengacher S; Dusonchet J; Aebischer P; Schneider BL
    Hum Mol Genet; 2012 Apr; 21(8):1861-76. PubMed ID: 22246294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of mitochondrial biogenesis by necdin protects neurons against mitochondrial insults.
    Hasegawa K; Yasuda T; Shiraishi C; Fujiwara K; Przedborski S; Mochizuki H; Yoshikawa K
    Nat Commun; 2016 Mar; 7():10943. PubMed ID: 26971449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
    Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
    J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf.
    Clark J; Silvaggi JM; Kiselak T; Zheng K; Clore EL; Dai Y; Bass CE; Simon DK
    PLoS One; 2012; 7(11):e48925. PubMed ID: 23145024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization.
    Eschbach J; von Einem B; Müller K; Bayer H; Scheffold A; Morrison BE; Rudolph KL; Thal DR; Witting A; Weydt P; Otto M; Fauler M; Liss B; McLean PJ; Spada AR; Ludolph AC; Weishaupt JH; Danzer KM
    Ann Neurol; 2015 Jan; 77(1):15-32. PubMed ID: 25363075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin functionally interacts with PGC-1α to preserve mitochondria and protect dopaminergic neurons.
    Zheng L; Bernard-Marissal N; Moullan N; D'Amico D; Auwerx J; Moore DJ; Knott G; Aebischer P; Schneider BL
    Hum Mol Genet; 2017 Feb; 26(3):582-598. PubMed ID: 28053050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human dopaminergic neurons.
    Mäkelä J; Tselykh TV; Kukkonen JP; Eriksson O; Korhonen LT; Lindholm D
    Neuropharmacology; 2016 Mar; 102():266-75. PubMed ID: 26631533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult Conditional Knockout of PGC-1α Leads to Loss of Dopamine Neurons.
    Jiang H; Kang SU; Zhang S; Karuppagounder S; Xu J; Lee YK; Kang BG; Lee Y; Zhang J; Pletnikova O; Troncoso JC; Pirooznia S; Andrabi SA; Dawson VL; Dawson TM
    eNeuro; 2016; 3(4):. PubMed ID: 27622213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells.
    Valle I; Alvarez-Barrientos A; Arza E; Lamas S; Monsalve M
    Cardiovasc Res; 2005 Jun; 66(3):562-73. PubMed ID: 15914121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons.
    Ye Q; Huang W; Li D; Si E; Wang J; Wang Y; Chen C; Chen X
    Mol Neurobiol; 2016 Aug; 53(6):3756-3770. PubMed ID: 26141122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXO3 determines the accumulation of α-synuclein and controls the fate of dopaminergic neurons in the substantia nigra.
    Pino E; Amamoto R; Zheng L; Cacquevel M; Sarria JC; Knott GW; Schneider BL
    Hum Mol Genet; 2014 Mar; 23(6):1435-52. PubMed ID: 24158851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ -treated MN9D cells in vitro.
    Sivasubramanian M; Kanagaraj N; Dheen ST; Tay SS
    Neuroscience; 2015 Apr; 290():636-48. PubMed ID: 25637806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glia Maturation Factor Dependent Inhibition of Mitochondrial PGC-1α Triggers Oxidative Stress-Mediated Apoptosis in N27 Rat Dopaminergic Neuronal Cells.
    Selvakumar GP; Iyer SS; Kempuraj D; Raju M; Thangavel R; Saeed D; Ahmed ME; Zahoor H; Raikwar SP; Zaheer S; Zaheer A
    Mol Neurobiol; 2018 Sep; 55(9):7132-7152. PubMed ID: 29383690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
    Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192190
    [No Abstract]   [Full Text] [Related]  

  • 17. Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease.
    Mudò G; Mäkelä J; Di Liberto V; Tselykh TV; Olivieri M; Piepponen P; Eriksson O; Mälkiä A; Bonomo A; Kairisalo M; Aguirre JA; Korhonen L; Belluardo N; Lindholm D
    Cell Mol Life Sci; 2012 Apr; 69(7):1153-65. PubMed ID: 21984601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathology of partial PGC-1α deficiency recapitulates features of mitochondrial encephalopathies but not of neurodegenerative diseases.
    Szalardy L; Zadori D; Plangar I; Vecsei L; Weydt P; Ludolph AC; Klivenyi P; Kovacs GG
    Neurodegener Dis; 2013; 12(4):177-88. PubMed ID: 23406886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
    Coune PG; Bensadoun JC; Aebischer P; Schneider BL
    J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neurons.
    Ulusoy A; Björklund T; Buck K; Kirik D
    Neurobiol Dis; 2012 Sep; 47(3):367-77. PubMed ID: 22659302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.